Zydus Cadila: A year of unparalleled growth

Singapore:  Cadila Healthcare, India Chairman: Mr Pankaj R PatelRevenue: $1285.6 mnBusiness: Discovery, development, m...

July 9, 2015 | Thursday | Analysis
ABIVAX to market typhoid, meningococcus vaccines in Asia

Singapore: ABIVAX, Europe-based clinical stage biopharmaceutical company developing and commercializing anti-viral compo...

November 18, 2014 | Tuesday | News
India continues to lead China in pharma exports

Singapore: India has maintained its lead over China in terms of pharma exports, according to a statement by the ministry...

July 22, 2016 | Friday | News
LifeCell offers Dual Storage of stem cells

Singapore: LifeCell International, India's largest stem cell storage company, announced the launch of India's first Dual...

December 21, 2012 | Friday | News
Wockhardt increases investment in R&D

Singapore: Addressing shareholders in the company's annual report, Indian drugmaker Wockhardt said that the company plan...

September 7, 2015 | Monday | News
Eli Lilly's corporate social responsibility impact

For more than 135 years, Eli Lilly and Company has demonstrated a commitment to be a responsible global citizen, in larg...

April 23, 2013 | Tuesday | Opinion
Europe plants €3.7 billion in bio-based economy

Singapore: European Commission president Mr José Manuel Barroso, and Commissioner for Research, Innovation and Scienc...

July 17, 2014 | Thursday | News
Glenmark bags FDA approval for skin ointment

Singapore: Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food &...

July 26, 2016 | Tuesday | News
Lupin gets FDA nod for generic Ortho Tri-cyclen Lo Tablets

Mumbai: Mumbai-based pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received approval for its Norgestimate ...

July 5, 2012 | Thursday | Regulatory
Lupin inks strategic JV agreement with Yoshindo

Singapore: Pharma Major, Lupin Limited announced today that it has entered into a strategic joint venture agreement with...

April 24, 2014 | Thursday | News
Ten top Indian life science collaborations of 2012

As the market for new drugs evolves, the methodologies for moving them into the market is changing and becoming more com...

March 26, 2013 | Tuesday | Analysis
APAC multiple myeloma market to value $2.8 bn by 2021: Report

Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...

October 23, 2015 | Friday | Analysis
India slashes prices of 54 essential drugs

Singapore: With a view to make medicines for critical diseases more affordable, India's National Pharmaceutical Pricing ...

May 12, 2016 | Thursday | News
Baxter erects global R&D center at Syngene

Bangalore: Baxter has constructed its R&D center at Biocon's Syngene facility. The facility, which was developed a...

February 5, 2014 | Wednesday | News
India's Biological E to buy French Valneva's CMO unit

Singapore: France-based biotech firm Valneva is selling its clinical manufacturing operations (CMO) in Nantes to India-b...

June 11, 2013 | Tuesday | News
Lupin gets 16 FDA nods, launches 11 products front

US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FD...

June 4, 2013 | Tuesday | Analysis
FDA approves Sun Pharma's generic Prandin

Singapore: The US Food and Drug Administration (FDA) has given its finally approval to India's Sun Pharmaceutical Indust...

July 12, 2013 | Friday | Regulatory
Singapore's Fortis Surgical Hospital is now Concord Medical Services

Singapore: Concord Medical Services, China based hospital management solution provider, has received Singapore's approva...

October 16, 2015 | Friday | News